Invest ASEAN Singapore Conference

Broker's Calls

Raffles Medical Group to retain its vigour in the face of near-term headwinds

SINGAPORE (March 29): Maybank Kim Eng Research is reiterating its “buy” call on Raffles Medical Group at an unchanged price target of $1.70, after having hosted the private healthcare provider at its recent Invest ASEAN Singapore Conference.
×